Thursday, December 27, 2012
Demystifying Routine Care Coverage in Trial Budgeting
Thought Leaders: Jessica Dolfi, MS, Senior Business Consultant, Medidata Solutions Worldwide and Kelly Willenberg, MBA, BSN, CHRC, CHC, Kelly Willenberg, LLC
In this episode, we discuss standard of care in clinical trials, challenges for sites and sponsors, and how standard of care issues affect day-to-day work in trials.
For more information about Medidata Solutions Worldwide, visit www.mdsol.com.
Play Podcast.
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Labels:
clinical trials,
healthcare,
medidata,
podcast,
standard of care
Friday, November 16, 2012
Women's Health Issues in Clinical Research: Key Post-approval Challenges
Thought Leaders: Jessica Albano, PhD, MPH, Senior Director, Epidemiology, Post Approval & Strategic Services, and Dr. Vikki Brown, Medical Director for the Post-Approval and Strategic Services division of INC Research, Inc.
In this episode, our experts discuss the primary challenges regarding women's health in clinical research. They also cover pregnancy registries and lactation studies, as well as available regulatory guidance related to this type of research.
For more information about INC Research, visit www.incresearch.com.
Play Podcast.
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Thursday, November 15, 2012
Informed Targeting to Healthcare Professionals
Thought Leader: R.J. Lewis, President & CEO, eHealthcare Solutions
In this episode, Mr. Lewis discusses how pharma can better connect with HCP audiences using authentication, list matching, and other techniques. He also covers how effective communications can impact prescription writing, and how to overcome hurdles from Medical, Legal, and Regulatory (MLR) departments.
For more information about eHealthcare Solutions, visit www.ehealthcaresolutions.com.
Play Podcast.
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Labels:
authentication,
eHealthcare,
HCP,
legal,
medical,
podcast,
regulatory
Friday, October 05, 2012
Untangling Alzheimer's Disease
Thought Leader: Prof. Claude Wischik, M.D., Ph.D., TauRx Therapeutics
In this episode, Professor Wischik describes his ongoing journey of research and development for Alzheimer's Disease. This intriguing podcast covers the man, the molecule, and the market.
For more information about TauRx Therapeutics, visit www.taurx.com.
Play Podcast.
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Labels:
alzheimers,
alzheimers disease,
drug development,
podcast
Thursday, October 04, 2012
How to Tap the Pharmacy for Clinical Trial Patients
Thought Leaders: Steve Hoffman, RPh, Chief Pharmacy Officer, McKesson Patient Relationship Solutions, Lynda Stout, PharmD, Lombard Health Mart Pharmacy
In this episode, our experts discuss pharmacy-based patient recruitment programs for clinical trials.
For more information about McKesson, visit www.mckesson.com.
Play Podcast.
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Tuesday, October 02, 2012
What are ACOs and Why Should You Care?
Thought Leader: Anthony D. Slonim, MD, DrPH, Executive Vice President and Chief Medical Officer, Barnabas Health. Sponsored: by CMR Institute
In this episode, Dr. Slonim discusses ACOs, how they offer a new model for health care, how they create opportunities for biopharmaceutical companies, and how a shift to ACOs would affect all facets of the health care continuum.
For more information about CMR Institute, visit www.cmrinstitute.org.
Play Podcast.
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Friday, September 28, 2012
Successful Email Marketing Methods: How to Boost Response by 400% or More
Thought Leader: Terry Nugent, Executive Vice President, Sales and Marketing, MMS, Inc.
In this episode, Mr. Nugent discusses the challenges of using email in pharmaceutical marketing, as well as some best practices for achieving the highest possible ROI.
For more information about MMS, visit www.mmslists.com.
Play Podcast.
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Labels:
email marketing,
MMS,
pharma marketing,
pharmaceutical marketing,
podcast,
ROI
Friday, August 31, 2012
Reaching Healthcare Providers While Remaining Compliant
Thought Leader: Erez Lapsker, CEO, MediScripts
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Labels:
hcp marketing,
mediscripts,
pharmavoice,
podcast,
prescription pads
Global Biosimilar Development
Thought Leader: Rodeina Challand, Executive Director, Biosimilars Development, PRA International
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Labels:
biosimilars,
drug development,
pharmavoice,
PRA,
PRA INternational
Future of Pharmacovigilance: Five Imperatives that will Drive Improved Business
Thought Leaders: Nagaraja Srivatsan, SVP, Head of Life Sciences, North America at Cognizant Venkat Venkataramanan, Director, Pharmacovigilance Domain Head, Cognizant, George Botsakos, Senior Director and Life Sciences R&D Leader in Cognizant's Business Consulting group
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Monday, July 09, 2012
Improve Adherence with Patient and Caregiver Support Programs
Thought Leader: Lou Shapiro, Senior VP, Business Development, Tunstall AMAC Life Sciences
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Tuesday, June 12, 2012
Influencing the Real Decision Makers: 7 Lenses For Marketing Health to Women
Thought Leaders: Chris DeAngelis, VP, Sales, SSI and Jonathan Kay, Head of Healthcare, Penn Schoen Berland
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Labels:
behaviors,
caregivers,
health,
penn schoen berland,
SSI,
women
Friday, June 08, 2012
Understanding Patients in the Emerging Market of Russia
Thought Leader: Gina Isherwood, Ph.D., Regional Brand Director, Kantar Health
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Wednesday, May 02, 2012
Top Ten Patient Enrollment and Retention Myths
In this episode, Mr. Connor shares 4 of his top 10 myths about patient enrollment and retention, and we'll tell you where to get the entire list.
For more information about Acurian, visit www.acurian.com.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Thursday, April 12, 2012
Patient Access to Investigational Drugs: Removing Barriers
Thought Leader: Simon Estcourt, Senior VP, Strategy and Corporate Development, Idis
In this episode, Mr. Estcourt shares his perspective on programs that enable patient access to medicines outside the clinical trial or commercial setting and the barriers that remain despite well-defined regulations governing such access.
Play Podcast
In this episode, Mr. Estcourt shares his perspective on programs that enable patient access to medicines outside the clinical trial or commercial setting and the barriers that remain despite well-defined regulations governing such access.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Tuesday, April 03, 2012
Insights from the Field: Tele-Sales Builds Relationships between Brand and HCPs
Thought Leader: Lou Shapiro, Senior VP, Business Development, PhoneScreen, an AMAC company
In this episode, Mr. Shapiro describes his experiences working with companies on successful tele-detailing and tele-sales programs, including numerous insights on the unforeseen benefits of these solutions.
Play Podcast
In this episode, Mr. Shapiro describes his experiences working with companies on successful tele-detailing and tele-sales programs, including numerous insights on the unforeseen benefits of these solutions.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Wednesday, March 28, 2012
DIA 2012 48th Annual Meeting Preview
Thought Leader: Craig Lipset, DIA Conference Chair, Head of Clinical Innovation, Development Operations within Worldwide Research & Development, Pfizer
In this episode of the PharmaVOICE Executive Suite Podcast Series, Mr. Lipset shares his thoughts on being Chairman of the DIA 2012 48th Annual Meeting in June, and how his work at Pfizer helps him in his role with DIA including this year's theme on collaboration. He also comments on how industry trends will impact drug development and clinical trials, and offers a couple tips on getting the most out of this year's DIA Annual Meeting in Philadelphia.
Play Podcast
In this episode of the PharmaVOICE Executive Suite Podcast Series, Mr. Lipset shares his thoughts on being Chairman of the DIA 2012 48th Annual Meeting in June, and how his work at Pfizer helps him in his role with DIA including this year's theme on collaboration. He also comments on how industry trends will impact drug development and clinical trials, and offers a couple tips on getting the most out of this year's DIA Annual Meeting in Philadelphia.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Thursday, February 02, 2012
Understanding the Impact of Drug Induced Liver Injury on Drug Development
Thought Leader: Steve Lobel, PhD, D-ABMLI, MBA, FACB, Vice-president Global Laboratory Operations, PPD
In this episode, Dr. Lobel talks about Drug-induced liver injury, also known as DILI. We'll cover what DILI is, how it is identified, and its effects on the clinical development process. At the end of this podcast, you'll learn where you can download a related white paper on this topic.
Play Podcast
In this episode, Dr. Lobel talks about Drug-induced liver injury, also known as DILI. We'll cover what DILI is, how it is identified, and its effects on the clinical development process. At the end of this podcast, you'll learn where you can download a related white paper on this topic.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
The Evolving Social Media Lifecycle in Pharma
Thought Leaders: Nagaraja Srivatsan, Dileep Srinivasan, and Alexander Gochtovtt, Cognizant
In this episode, a trio of experts from Cognizant talk about numerous issues involving social media in the life sciences. There is also a related white paper you may download.
Play Podcast
In this episode, a trio of experts from Cognizant talk about numerous issues involving social media in the life sciences. There is also a related white paper you may download.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
How the New Role of the CRO Affects Patient Enrollment
Thought Leader: Richard Malcolm, CEO, Acurian
In this episode, Dr. Malcolm discusses how the role of the CRO is transitioning from commodity service supplier to strategic partner, and the unintended negative consequences this could have on what is already the most expensive part of clinical trials: patient enrollment.
Play Podcast
In this episode, Dr. Malcolm discusses how the role of the CRO is transitioning from commodity service supplier to strategic partner, and the unintended negative consequences this could have on what is already the most expensive part of clinical trials: patient enrollment.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Wednesday, February 01, 2012
Transformative Leadership
Thought Leader: Dr. Deborah Dunsire, President and CEO, Millennium: The Takeda Oncology Company
In this episode, Dr. Dunsire shares her insights on the quest to find a cure for cancer, on women striving for positions in the C-Suite, and thoughts on her own career development and recognition as the 2009 HBA Woman of the Year.
Play Podcast
In this episode, Dr. Dunsire shares her insights on the quest to find a cure for cancer, on women striving for positions in the C-Suite, and thoughts on her own career development and recognition as the 2009 HBA Woman of the Year.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Wednesday, January 04, 2012
Automating Pharma FCPA Due Diligence
Thought Leader: Robert Shecterle, Vice President of Marketing, Aravo
In this episode, Mr. Shecterle discusses FCPA Compliance and anti-bribery practices at large pharmaceutical and life sciences companies.
Play Podcast
In this episode, Mr. Shecterle discusses FCPA Compliance and anti-bribery practices at large pharmaceutical and life sciences companies.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
The C-Suite: How Biotech Improves the Standard of Care of Patients
Thought Leader: Brad Thompson, Ph.D., Chairman, President and CEO, Oncolytics Biotech
In this episode, Dr. Thompson talks about how biotech is making improvements in the standard of care, and the impact of Pharma 3.0. He also talks about his own experience taking REOLYSIN® through the drug development process, the genesis of Oncolytics Biotech, and shares some insights for biotech entrepreneurs.
Play Podcast
In this episode, Dr. Thompson talks about how biotech is making improvements in the standard of care, and the impact of Pharma 3.0. He also talks about his own experience taking REOLYSIN® through the drug development process, the genesis of Oncolytics Biotech, and shares some insights for biotech entrepreneurs.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Understanding How Social Networks Drive Healthcare Decisions: Mapping a New "Influence" Landscape
Thought Leader: Chris DeAngelis, Vice President, Strategic Initiatives, SSI
In this episode, Mr. DeAngelis discusses a variety of issues regarding consumers' usage of social media for healthcare information. You'll learn some of the results of a study of over 1,400 U.S. consumers participating in proprietary panels and web communities.
Play Podcast
In this episode, Mr. DeAngelis discusses a variety of issues regarding consumers' usage of social media for healthcare information. You'll learn some of the results of a study of over 1,400 U.S. consumers participating in proprietary panels and web communities.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Tele-detailing: Responding to Changing Pharma Sales Models
Thought Leader: Lou Shapiro, Senior Vice President, AMAC Services Group and the PhoneScreen brand
In this episode, Mr. Shapiro talks about the challenges life science companies face when providing information on their products to physicians and healthcare providers.
Play Podcast
In this episode, Mr. Shapiro talks about the challenges life science companies face when providing information on their products to physicians and healthcare providers.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Tuesday, January 03, 2012
Additive Patient Recruitment
Thought Leader: Roger Smith, Senior Vice President, Operations, Acurian
In this episode, Mr. Smith talks about clinical trial enrollment and the concept of Additive Patient Recruitment.
Play Podcast
In this episode, Mr. Smith talks about clinical trial enrollment and the concept of Additive Patient Recruitment.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Subscribe to:
Posts (Atom)